Literature DB >> 18519682

Long-term in vitro expansion alters the biology of adult mesenchymal stem cells.

Reza Izadpanah1, Deepak Kaushal, Christopher Kriedt, Fern Tsien, Bindiya Patel, Jason Dufour, Bruce A Bunnell.   

Abstract

Mesenchymal stem cells (MSC) derived from bone marrow stem cells (BMSC) and adipose tissue stem cells (ASC) of humans and rhesus macaques were evaluated for their cell cycle properties during protracted culture in vitro. Human ASCs (hASC) and rhesus BMSCs (rBMSC) underwent significantly more total population doublings than human BMSCs (hBMSC) and rhesus ASCs (rASC). The cell cycle profile of all MSCs was altered as cultures aged. hMSCs underwent an increase in the frequency of cells in the S phase at P20 and P30. However, rhesus MSCs from both sources developed a distinct polyploid population of cells at P20, which progressed to aneuploidy by P30. Karyotype analysis of MSCs revealed the development of tetraploid or aneuploid karyotypes in the rhesus cells at P20 or P30. Analysis of the transcriptome of the MSCs from early and late passages revealed significant alterations in the patterns of gene expression (8.8% of the genes were differentially expressed in hBMSCs versus hASCs, and 5.5% in rBMSCs versus rASCs). Gene expression changes were much less evident within the same cell type as aging occurred (0.7% in hMSCs and 0.9% in rMSC). Gene ontology analysis showed that functions involved in protein catabolism and regulation of pol II transcription were overrepresented in rASCs, whereas the regulation of I kappa B/nuclear factor-kappaB cascade were overrepresented in hBMSCs. Functional analysis of genes that were differentially expressed in rASCs and hBMSCs revealed that pathways involved in cell cycle, cell cycle checkpoints, protein-ubiquitination, and apoptosis were altered.

Entities:  

Mesh:

Year:  2008        PMID: 18519682      PMCID: PMC2713721          DOI: 10.1158/0008-5472.CAN-07-5272

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations.

Authors:  J D Chismar; T Mondala; H S Fox; E Roberts; D Langford; E Masliah; D R Salomon; S R Head
Journal:  Biotechniques       Date:  2002-09       Impact factor: 1.993

2.  Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines.

Authors:  Qinghua Shi; Randall W King
Journal:  Nature       Date:  2005-10-13       Impact factor: 49.962

3.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

4.  Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue.

Authors:  Reza Izadpanah; Cynthia Trygg; Bindiya Patel; Christopher Kriedt; Jason Dufour; Jeffery M Gimble; Bruce A Bunnell
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

5.  Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis.

Authors:  Yasuo Miura; Masako Miura; Stan Gronthos; Matthew R Allen; Chunzhang Cao; Thomas E Uveges; Yanming Bi; Driss Ehirchiou; Angela Kortesidis; Songtao Shi; Li Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

6.  Characterization of multipotent mesenchymal stem cells from the bone marrow of rhesus macaques.

Authors:  Reza Izadpanah; Tanya Joswig; Fern Tsien; Jason Dufour; J Chrisitian Kirijan; Bruce A Bunnell
Journal:  Stem Cells Dev       Date:  2005-08       Impact factor: 3.272

7.  Comparison of non-human primate and human whole blood tissue gene expression profiles.

Authors:  James F Dillman; Christopher S Phillips
Journal:  Toxicol Sci       Date:  2005-06-23       Impact factor: 4.849

8.  Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.

Authors:  Takeshi Fujiwara; Madhavi Bandi; Masayuki Nitta; Elena V Ivanova; Roderick T Bronson; David Pellman
Journal:  Nature       Date:  2005-10-13       Impact factor: 49.962

9.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  Aging of mesenchymal stem cell in vitro.

Authors:  Mandana Mohyeddin Bonab; Kamran Alimoghaddam; Fatemeh Talebian; Syed Hamid Ghaffari; Ardeshir Ghavamzadeh; Behrouz Nikbin
Journal:  BMC Cell Biol       Date:  2006-03-10       Impact factor: 4.241

View more
  117 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

Review 2.  Brief review of models of ectopic bone formation.

Authors:  Michelle A Scott; Benjamin Levi; Asal Askarinam; Alan Nguyen; Todd Rackohn; Kang Ting; Chia Soo; Aaron W James
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

3.  Defining essential stem cell characteristics in adipose-derived stromal cells extracted from distinct anatomical sites.

Authors:  Patrick C Sachs; Michael P Francis; Min Zhao; Jenni Brumelle; Raj R Rao; Lynne W Elmore; Shawn E Holt
Journal:  Cell Tissue Res       Date:  2012-05-25       Impact factor: 5.249

Review 4.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 5.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

6.  Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells.

Authors:  Benjamin L Larson; Joni Ylostalo; Ryang H Lee; Carl Gregory; Darwin J Prockop
Journal:  Tissue Eng Part A       Date:  2010-07-13       Impact factor: 3.845

7.  Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Authors:  Igor B Resnick; Claudine Barkats; Michael Y Shapira; Polina Stepensky; Allan I Bloom; Avichai Shimoni; David Mankuta; Nira Varda-Bloom; Lyudmila Rheingold; Moshe Yeshurun; Bella Bielorai; Amos Toren; Tsila Zuckerman; Arnon Nagler; Reuven Or
Journal:  Am J Blood Res       Date:  2013-08-19

8.  Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow.

Authors:  Torben Helledie; Christian Dombrowski; Bina Rai; Zophia X H Lim; Ian Lee Hock Hin; David A Rider; Gary S Stein; Wanjin Hong; Andre J van Wijnen; James H Hui; Victor Nurcombe; Simon M Cool
Journal:  Stem Cells Dev       Date:  2012-01-18       Impact factor: 3.272

9.  Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints.

Authors:  Jaewoo Pak; Jae-Jin Chang; Jung Hun Lee; Sang Hee Lee
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

10.  Characterization of mechanical and regenerative properties of human, adipose stromal cells.

Authors:  Manisha Kanthilal; Eric M Darling
Journal:  Cell Mol Bioeng       Date:  2014-12       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.